The therapeutic armamentarium for inflammatory bowel disease (IBD) is expanding with the advent of anti–IL-23 therapies. The unique clinical profiles of new and emerging agents make it necessary that treatment decisions are guided by evolving knowledge of the science surrounding …
The therapeutic armamentarium for inflammatory bowel disease (IBD) is expanding with the advent of anti–IL-23 therapies. The unique clinical profiles of new and emerging agents make it necessary that treatment decisions are guided by evolving knowledge of the science surrounding …
Lennox-Gastaut syndrome (LGS) remains a challenging condition to understand, diagnose, and manage. Neuroscience/neurology clinicians, including nurses and nurse practitioners (NPs), encounter significant challenges in the management of patients with LGS, due to the severe symptoms and morbidities, diagnostic delays, and …
Lennox-Gastaut syndrome (LGS) remains a challenging condition to understand, diagnose, and manage. Neuroscience/neurology clinicians, including nurses and nurse practitioners (NPs), encounter significant challenges in the management of patients with LGS, due to the severe symptoms and morbidities, diagnostic delays, and …
It is critically important that health care professionals screen for and diagnose Alzheimer’s disease (AD) in its early stages when symptoms are subtle and resemble normal aging, as brain changes may start years before symptoms manifest and the underlying pathology …
Recent advances in the treatment of gynecologic cancers are promising, and education is needed to ensure that both oncology and primary care clinicians, including OB/GYNs, have a thorough knowledge of biomarkers, current and emerging therapies, and how the latest clinical …
In recent years there has been an upsurge of new biologics and small-molecule therapies for ulcerative colitis (UC), making it challenging for the UC interdisciplinary care team (such as gastroenterologists, physician associates, and nurse practitioners) to stay abreast of these …
Current guidelines for antiretroviral therapy (ART) treatments for HIV do not necessarily include new treatment regimens for special populations such as those who are pregnant, have drug-resistant HIV, or comorbid conditions such as HBV. Health care practitioners (HCPs) therefore require …
